The Biotechnology Innovation Organization (BIO) this week announced the launch of a new coalition to raise public awareness of antimicrobial resistance (AMR) and advocate for policies to stimulate new antibiotic development.

The “Working to Fight AMR” coalition will be led by BIO, a trade organization that represents biotechnology companies and related organizations, and will include scientists, public policy experts, and industry leaders. The group says that, in addition to educating the public, it will advocate for policies like the DISARM Act, which calls for higher Medicare reimbursement for new antibiotics that treat serious or life-threatening infections.

“Antimicrobial resistance already poses a grave threat to human health—and it is a looming public health emergency,” Greg Frank, PhD, BIO’s director of infectious disease policy, said in a press release. “Working to Fight AMR will advocate for policies to boost investment in this deeply neglected area.”

More from CIDRAP here.